In melanoma, increased expression of IDO1 or tryptophan 2,3-dioxygenase (TDO), another enzyme involved in metabolizing tryptophan to AhR ligands, increases the abundance of TAMs and polarizes to a more M2-like immunosuppressive phenotype [17]. Here, AHR is linked to melanoma.